Phase II study of sequential triplet chemotherapy, irinotecan and cisplatin followed by amrubicin, in patients with extensive-stage small cell lung cancer: West Japan Thoracic Oncology Group Study 0301.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples